Scientists have been peeking through microscopes and taking pictures of cells for decades. The methods available for visualizing highly complex cells have changed over time, moving from simpler ...
Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...
This article is based on a poster originally authored by Felix L-Perusse, Josiane Bourque, Martin Cottet, Simon Mathien, and David W. Andrews, which was presented at ELRIG Drug Discovery 2024 in ...
The advent of sophisticated cellular imaging techniques, combined with technological advances in automation and data collection and interpretation, has provided the basis for the development of ...
Modern day drug discovery is shifting from single end point assays to more complex phenotypic assays that query single cell and population responses to chemicals and genetic manipulation. One such ...
MONTREAL & BOSTON--(BUSINESS WIRE)--Nomic Bio ("Nomic"), the protein profiling company, announced today that it is providing access to the company’s nELISA TM platform to the Joint Undertaking in ...
Today, nine out of ten drugs fail in clinical trials. Furthermore, it takes over a decade and an average cost of $2 billion to develop and approve each medicine. 1 An important underlying reason is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback